ciprofloxacin and gentian violet

ciprofloxacin has been researched along with gentian violet in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's5 (38.46)29.6817
2010's5 (38.46)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Elkins, CA; Mullis, LB1
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K1
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R1
Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW1
Bailey, AM; Paulsen, IT; Piddock, LJ1
Kamal, N; Shafer, WM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Elkins, CA; Jung, CM; Lacher, DW; Mullis, LB1
Nakaminami, H; Noguchi, N; Sasatsu, M1
Beatty, JA; Kendall, K; Malik, R; Martin, P1
Suci, P; Young, M1
Asadi Karam, MR; Foroohi, F; Habibi, M; Haji Hossein Tabrizi, A; Mohammadian, T1
Chhibber, S; Harjai, K; Mangal, S; Singh, V1

Other Studies

13 other study(ies) available for ciprofloxacin and gentian violet

ArticleYear
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding, Competitive; Carrier Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Indicators and Reagents; Microbial Sensitivity Tests; Progesterone; Steroids

2007
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents

2007
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins

2007
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin

2008
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Anti-Bacterial Agents; Antipsychotic Agents; Bacterial Proteins; Base Sequence; Chlorpromazine; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethidium; Gene Expression; Genes, Bacterial; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Oligonucleotide Array Sequence Analysis; Phenothiazines; Salmonella typhimurium; Trans-Activators

2008
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Escherichia coli; Escherichia coli Proteins; Genetic Complementation Test; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Neisseria meningitidis

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Catfishes; Cattle; Disease Reservoirs; Escherichia coli; Escherichia coli Proteins; Feces; Gene Expression Regulation, Bacterial; Intestines; Mice; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Mutation; Phylogeny; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Rats; Recombination, Genetic; Sequence Analysis, DNA; Structure-Activity Relationship

2010
Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Fluoroquinolones; Membrane Transport Proteins; Plasmids; Staphylococcus aureus

2010
Haematuria in a geriatric cat.
    Australian veterinary journal, 1999, Volume: 77, Issue:3

    Topics: Animals; Anti-Infective Agents; Azure Stains; Carcinoma, Transitional Cell; Cat Diseases; Cats; Ciprofloxacin; Fatal Outcome; Gentian Violet; Hematuria; Histocytochemistry; Male; Methylene Blue; Phenazines; Staining and Labeling; Ultrasonography; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Tract Infections; Xanthenes

1999
Selective killing of Aggregatibacter actinomycetemcomitans by ciprofloxacin during development of a dual species biofilm with Streptococcus sanguinis.
    Archives of oral biology, 2011, Volume: 56, Issue:10

    Topics: Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Anti-Infective Agents; Bacterial Load; Bacteriological Techniques; Biofilms; Biomass; Ciprofloxacin; Coloring Agents; DNA, Bacterial; Feasibility Studies; Female; Fluorescent Antibody Technique; Gentian Violet; Humans; Microbial Interactions; Microscopy, Confocal; Streptococcus; Time Factors

2011
Investigation of the effects of antimicrobial and anti-biofilm peptide IDR1018 and chitosan nanoparticles on ciprofloxacin-resistant Escherichia coli.
    Journal of basic microbiology, 2022, Volume: 62, Issue:10

    Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Chitosan; Ciprofloxacin; Escherichia coli Infections; Gentian Violet; Humans; Microbial Sensitivity Tests; Nanoparticles; Uropathogenic Escherichia coli

2022
Guaiacol augments quorum quenching potential of ciprofloxacin against Pseudomonas aeruginosa.
    Journal of applied microbiology, 2022, Volume: 133, Issue:4

    Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Gentian Violet; Guaiacol; Pseudomonas aeruginosa; Quorum Sensing; Sodium Dodecyl Sulfate; Virulence Factors

2022